NetworkNewsBreaks

WednesdayJun 21, 2017 3:03 pm

NetworkNewsBreaks – Moleculin Biotech, Inc. (NASDAQ: MBRX) Reports Discovery of Metabolic Inhibitor with Potential to Treat Pancreatic Cancer; Shares Rise

Shares of Moleculin Biotech (NASDAQ: MBRX) are up more than 30% after the company said that WP1234, a metabolic inhibitor, is a positive drug candidate to be studied for the potential to treat pancreatic cancer. Pancreatic cancer is still considered mostly untreatable, so any improvement in treating this disease could symbolize a significant clinical benefit. "We have identified possible new properties of our compound WP1234, a modification to WP1122. In pre-clinical testing, WP1234 has shown improved drug characteristics when compared with WP1122 and a 20 to 50-fold greater ability to kill pancreatic cancer cell lines when compared with traditional inhibitors…

Continue Reading

WednesdayJun 21, 2017 3:00 pm

NetworkNewsBreaks – Grow Condos, Inc. (GRWC) Provides Positive Update on ‘Smoke on the Water’ at Lake Selmac

Grow Condos (OTCQB: GRWC) this morning provided an update on "Smoke on the Water" at Lake Selmac, the company’s resort designed to cater to and capitalize on the country's persistently increasing level of recreational marijuana acceptance. The company reports that the park is undergoing a series of alterations, including culturally diverse upgrades and added value services for patrons of the resort. Among the highlights of the park’s changing atmosphere are the delivery of its tee-pees for its Native American section, which also features yoga and other spiritually enhancing activities. "Smoke on the Water" has launched its own roll up development…

Continue Reading

WednesdayJun 21, 2017 12:33 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on June 21, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: MBRX 28.31% – News: Reports discovery of metabolic inhibitor with potential to treat pancreatic cancer SHIP 15.94% – News: Posts new corporate presentation on its website PRGE 15.76% – News: Grupo subsidiary contracts to purchase a warehouse facility in Dallas, Texas SKYS 15.07% – News: Law firm notifies investors of a class action lawsuit CXRX 9.37% – News: Provides long-term growth strategy update BIOC 6.15% – News: Enters agreement with MediNcrease BDSI 5.77% –…

Continue Reading

WednesdayJun 21, 2017 12:32 pm

NetworkNewsBreaks – Trevena, Inc. (NASDAQ: TRVN) Reiterated with “Buy” Rating at Aegis Capital

Aegis Capital has reiterated a ‘Buy’ rating and price target of $14 on shares of Trevena, Inc. (NASDAQ: TRVN) following the company’s recent management meetings. Among other highlights from the meetings, the analyst noted Trevena’s completion of pre-launch commercial activity. Trevena has completed interviews with around 140 pharmacy directors and 40 anesthesiologists regarding Olinvo. As for the investors' concerns regarding the launch of Olinvo in the U.S., the analyst believes it is worth launching and could be a product with peak year revenue in the range of $200 million-$300 million. For more information, visit www.trevena.com About Trevena  Trevena, Inc. is…

Continue Reading

WednesdayJun 21, 2017 12:30 pm

NetworkNewsBreaks – Aegis Capital Reiterates “Buy” Rating on Axsome Therapeutics, Inc. (NASDAQ: AXSM)

Following Axsome Therapeutics, Inc.’s (NASDAQ: AXSM) appointment of Myrtle Potter to its board of directors, Aegis Capital reiterated its ‘Buy’ rating and price target of $20 on shares of the company’s stock. Calling the appointment “incrementally positive,” the analyst voiced confidence that the appointment of the former Genentech executive, specifically her experience in the commercialization process, adds value to Axsome’s board. For more information, visit www.axsome.com About Axsome Therapeutics, Inc. Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders for which there are limited treatment options. Axsome’s product candidate…

Continue Reading

WednesdayJun 21, 2017 11:29 am

NetworkNewsBreaks – ORHub, Inc. (ORHB) Announces Exercise Price for Series B and D Warrants

Health care software-as-a-service company ORHub, Inc. (OTC: ORHB) today announced a $0.50 exercise price for all of its Series B and D warrants. Per this morning’s news release, the exercise price will commence immediately and remain in place until all of the related warrants have been exercised or have reached their expiration date, currently set at December 31, 2017. If all of the Series B and D warrants are exercised, the company estimates that it will receive more than $5.5 million in additional proceeds with which to fund the launch of its innovative software platform into hospital chains located throughout…

Continue Reading

WednesdayJun 21, 2017 9:32 am

NetworkNewsBreaks – SkyFidelity, Inc. (SRMX) Announces Merger with Saddle Ranch Media, Inc.

SRMX/SkyFidelity, Inc. (OTC: SRMX) this morning announced its successful merger with Saddle Ranch Media, Inc., effective May 10, 2017. In connection with this merger, the company intends to file the necessary documents to change the operating name and symbol of Saddle Ranch Media, Inc. to SkyFidelity, Inc. with corresponding ticker symbol “SKYX.” Per this morning’s update, the company anticipates that completion of all of the documentation necessary for filing and registration of the new operating name and symbol will occur by June 27, 2017. In addition to these efforts, SRMX/SkyFidelity this morning announced its intention to retain the services of…

Continue Reading

WednesdayJun 21, 2017 9:00 am

NetworkNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Teams with Payvision in Europe to Expand Access to Global Currencies

Net Element, Inc. (NASDAQ: NETE), through its PayOnline subsidiary, this morning announced the expansion of its list of integrations and partnerships in Europe through the addition of Payvision to its network of partners. Leveraging this partnership, PayOnline will gain an additional channel through which to route payments in Europe, effectively broadening the scope of its customers’ capabilities while supporting higher conversion rates and improved access to 120+ currencies globally. PayOnline’s work with Intui Travel, a website for searching and booking transportation online, demonstrates the potential benefits of the company’s partnership with Payvision. Per this morning’s news release, PayOnline was able…

Continue Reading

TuesdayJun 20, 2017 1:01 pm

NetworkNewsBreaks – Medical Robotics Maker Myomo, Inc. (NYSE: MYO) Trades on NYSE as First JOBS Act Regulation A+ Issuer

Myomo (NYSE MKT: MYO) is in its second week of trading on the NYSE, with shares moving in a range of $6.76-$23.19 thus far. The medical robotics company completed its crowdsourced initial public offering (IPO) on June 9, raising $5 million through the sale of 665,498 shares of its common stock, and, on June 16, it concluded its first week of trading by ringing the closing bell at the New York Stock Exchange in New York City. Myomo made history as the first Jumpstart Our Business Startups (JOBS) Act Regulation A+ issuer to trade on the NYSE MKT. To view…

Continue Reading

TuesdayJun 20, 2017 12:17 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on June 20, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: SGOC 32.40% – News: Enters contract with Hong Kong Aircraft Engineering SPEX 17.51% – News: Negotiates definitive terms to acquire a controlling interest in Hoth Therapeutics NVIV 8.33% – News: Enrolls new patient in INSPIRE Study at Allegheny General Hospital ABWN 5.57% – News: Inks software development deal with Thinking Different Technologies GLUU 4.74% – News: Enters multi-year agreement with WWE (NYSE: WWE) ONVI 4.71% – News: Releases its second-annual Survey of Government Procurement…

Continue Reading